FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.7  |  FHIR Version n/a  User: [n/a]

929360071000036103: Medicinal product unit of use reference set (foundation metadata concept)


Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3288211000168116 MPUU (medicinal product unit of use) reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507151000036113 Medicinal product unit of use reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module
965507161000036111 Medicinal product unit of use reference set en Synonym Active Case sensitive Australian Medicines Terminology module
4351141000168117 <p>Terminology to describe in a health record an abstract concept representing the properties of one or more equivalent Trade Product Units of Use.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module


7425 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Medicinal product unit of use reference set Developed by Australian Digital Health Agency true Inferred relationship Some 615170453
Medicinal product unit of use reference set Has licence SNOMED CT-AU licence​ true Inferred relationship Some 1364130978
Medicinal product unit of use reference set Is a Simple type reference set true Inferred relationship Some

Members
lidocaine hydrochloride 2% (44 mg/2.2 mL) + adrenaline (epinephrine) 1 in 100 000 (22 microgram/2.2 mL) injection, cartridge
mepivacaine hydrochloride 2% (44 mg/2.2 mL) + adrenaline (epinephrine) 1 in 100 000 (22 microgram/2.2 mL) injection, cartridge
lidocaine hydrochloride monohydrate 2% (36 mg/1.8 mL) + adrenaline (epinephrine) 1 in 80 000 (27.5 microgram/1.8 mL) injection, cartridge
lidocaine hydrochloride 2% (44 mg/2.2 mL) + adrenaline (epinephrine) 1 in 80 000 (27.5 microgram/2.2 mL) injection, cartridge
lidocaine hydrochloride monohydrate 2% (44 mg/2.2 mL) + adrenaline (epinephrine) 1 in 80 000 (27.5 microgram/2.2 mL) injection, cartridge
adrenaline (epinephrine) 300 microgram/0.3 mL injection, pen device
epinephrine 50 microgram / 5 mL + lidocaine hydrochloride 50 mg / 5 mL injection, 5 mL ampoule (medicinal product unit of use)
adrenaline (epinephrine) 500 microgram/0.3 mL injection, pen device
lidocaine hydrochloride 2% (100 mg/5 mL) + adrenaline (epinephrine) 1 in 80 000 (62.5 microgram/5 mL) injection, ampoule
prilocaine hydrochloride 3% (66 mg/2.2 mL) + adrenaline (epinephrine) 1 in 300 000 (7.26 microgram/2.2 mL) injection, cartridge
adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride 4% gel, vial
adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride monohydrate 4.24% solution, vial
epirubicin hydrochloride 10 mg/5 mL injection, vial
epirubicin hydrochloride 10 mg injection, vial
epirubicin hydrochloride 100 mg/50 mL injection, vial
epirubicin hydrochloride 150 mg/75 mL injection, vial
epirubicin hydrochloride 20 mg / 10 mL injection, 10 mL vial (medicinal product unit of use)
epirubicin hydrochloride 200 mg/100 mL injection, vial
epirubicin hydrochloride 50 mg/25 mL injection, vial
epirubicin hydrochloride 50 mg injection, vial
eplerenone 25 mg tablet
eplerenone 50 mg tablet
epoetin alfa 1000 international units / 0.5 mL injection, 0.5 mL syringe (medicinal product unit of use)
epoetin alfa 10 000 units/mL injection, syringe
epoetin alfa 2000 units/0.5 mL injection, syringe
epoetin alfa 20 000 units/0.5 mL injection, syringe
epoetin alfa 3000 units/0.3 mL injection, syringe
epoetin alfa 30 000 units/0.75 mL injection, syringe
epoetin alfa 4000 units/0.4 mL injection, syringe
epoetin alfa 40 000 units/mL injection, syringe
epoetin alfa 5000 international units / 0.5 mL injection, 0.5 mL syringe (medicinal product unit of use)
epoetin alfa 6000 units/0.6 mL injection, syringe
epoetin alfa 8000 units/0.8 mL injection, syringe
epoetin beta 1000 units/0.3 mL injection, syringe
epoetin beta 10 000 units/0.6 mL injection, syringe
epoetin beta 2000 units/0.3 mL injection, syringe
epoetin beta 20 000 units/0.6 mL injection, syringe
epoetin beta 3000 units/0.3 mL injection, syringe
epoetin beta 30 000 units/0.6 mL injection, syringe
epoetin beta 4000 units/0.3 mL injection, syringe
epoetin beta 5000 units/0.3 mL injection, syringe
epoetin beta 6000 units/0.3 mL injection, syringe
epoetin lambda 1000 units/0.5 mL injection, syringe
epoetin lambda 10 000 units/mL injection, syringe
epoetin lambda 2000 units/mL injection, syringe
epoetin lambda 3000 units/0.3 mL injection, syringe
epoetin lambda 4000 units/0.4 mL injection, syringe
epoetin lambda 5000 units/0.5 mL injection, syringe
epoetin lambda 6000 units/0.6 mL injection, syringe
epoetin lambda 7000 units/0.7 mL injection, syringe
epoetin lambda 8000 units/0.8 mL injection, syringe
epoetin lambda 9000 units/0.9 mL injection, syringe
epoprostenol 1.5 mg injection, vial
epoprostenol 500 microgram injection, vial
eprosartan 400 mg tablet
eprosartan 600 mg + hydrochlorothiazide 12.5 mg tablet
eprosartan 600 mg tablet
eptacog alfa (activated) 1 mg injection, vial
eptacog alfa (activated) 1.2 mg injection, vial
eptacog alfa (activated) 2 mg injection, vial
eptacog alfa (activated) 2.4 mg injection, vial
eptacog alfa (activated) 4.8 mg injection, vial
eptacog alfa (activated) 5 mg injection, vial
eptacog alfa (activated) 8 mg injection, vial
eptifibatide 20 mg / 10 mL injection, 10 mL vial (medicinal product unit of use)
eptifibatide 75 mg/100 mL injection, vial
eptinezumab 100 mg/mL injection, vial
erenumab 140 mg/mL injection, pen device
erenumab 140 mg/mL injection, syringe
erenumab 70 mg/mL injection, pen device
erenumab 70 mg/mL injection, syringe
ergocalciferol 25 microgram capsule
oxytocin 5 units/mL + ergometrine maleate 500 microgram/mL injection, ampoule
ergometrine maleate 500 microgram / 1 mL injection, 1 mL ampoule (medicinal product unit of use)
eribulin mesilate 1 mg / 2 mL injection, 2 mL vial (medicinal product unit of use)
erlotinib 100 mg tablet
erlotinib 150 mg tablet
erlotinib 25 mg tablet
ertapenem 1 g injection, vial
ertugliflozin 15 mg + sitagliptin 100 mg tablet
ertugliflozin 15 mg tablet
ertugliflozin 2.5 mg + metformin hydrochloride 1 g tablet
ertugliflozin 2.5 mg + metformin hydrochloride 500 mg tablet
ertugliflozin 5 mg + sitagliptin 100 mg tablet
ertugliflozin 5 mg tablet
ertugliflozin 7.5 mg + metformin hydrochloride 1 g tablet
ertugliflozin 7.5 mg + metformin hydrochloride 500 mg tablet
erythromycin (as ethylsuccinate) 200 mg/5 mL powder for oral liquid
erythromycin (as ethylsuccinate) 400 mg/5 mL powder for oral liquid
erythromycin (as ethylsuccinate) 400 mg tablet
erythromycin 1 g injection, vial
erythromycin 2% gel
erythromycin 250 mg enteric capsule
escitalopram 10 mg/mL oral liquid
escitalopram 10 mg tablet
escitalopram 15 mg tablet
escitalopram 20 mg/mL oral liquid
escitalopram 20 mg tablet
escitalopram 5 mg tablet
esketamine 28 mg/2 actuations nasal spray, actuation
eslicarbazepine acetate 200 mg tablet

Start Previous Page 32 of 75 Next End


Reference Sets

Australian dialect reference set

Reference set descriptor

Back to Start